Novo CEO sees obesity pill opening doors to new markets
Novo Nordisk A/S’s obesity pill will allow it to tap into a massive population of patients that have not yet taken GLP-1s , the drugmaker’s chief executive said. The pill version of its blockbuster obesity shot Wegovy will expand the market for these drugs, CEO Mike Doustdar said at an Endpoints event in San Francisco […]
Novo Nordisk sees pills capturing over third of GLP-1 obesity market by 2030 – Reuters
Novo Nordisk sees pills capturing over third of GLP-1 obesity market by 2030 Reuters
Dr. Drew Says GLP-1 Drugs May Have Helped Nick Reiner, But It’s Delicate Balance
Nick Reiner’s weight gain set him on a murderous path, but it didn’t have to be that way … just ask Dr. Drew. The good doc joined us on “TMZ Live” Monday and told us Nick likely would have benefited from being prescribed weight-loss drugs to…
#JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom
Pharma has much to learn from the surprising boom of telehealth sales of obesity drugs, Novo Nordisk’s CEO Mike Doustdar said at the Endpoints at #JPM26 event on the sidelines of the …
Pfizer CEO Bourla Says Company Looking For ‘Superior’ Results from Weight-Loss Drugs
Pfizer CEO Albert Bourla told Bloomberg’s Katie Greifeld Pfizer is looking for ‘superior results’ while developing and testing further GLP-1 weight loss medications in a crowded market. Bourla also commented on his company’s relationship with the Trump administration as businesses look for stability on pricing and tariffs. He told Bloomberg he is optimistic that uncertainty […]
Semaglutide Attenuates Neuroinflammation in Mice
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown promise in preclinical models of neurodegeneration, with emerging evidence suggesting these effects may be driven by modulation of neuroinflammation. However, the cellular mechanisms underlying GLP-1 RA effects on neuroinflammation remain poorly understood. Here, using a mouse model of lipopolysaccharide-induced neuroinflammation, we investigated how semaglutide coordinates cellular responses […]
New comment by Aurornis in “Ozempic reduced grocery spending by an average of 5.3% in the US”
> In my friend circle in Germany I don’t even know one single person on this stuff. Most people don’t announce when they’re taking a new medication. GLP-1 drugs are popular in Germany, too. Not quite to the level of some other countries but a quick search shows about 1 in 12 individuals in Germany. […]
Tom Brady joins telehealth startup to help sell GLP-1s
Of all the television personalities on GLP-1s like Ozempic, Tom Brady doesn’t appear to be one of them. You don’t play in the NFL into your mid-40s if you need help losing a few pounds. But the Fox Sports commentator will now be the new “face” of GLP-1s, at least according to a headline by […]
ASCO GI: GLP-1 Receptor Agonist Use Linked to Reduced CRC Incidence
MONDAY, Jan. 12, 2026 — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for colorectal cancer (CRC) incidence compared with aspirin, according to a study presented at the American Society of Clinical…
This GLP-1 mistake can make you gain weight 4 times faster than stopping diet and exercise
While GLP-1s boast impressive weight loss results, making one mistake could result in the pounds coming right back on, according to new research.